Association of GSTM1, GSTT1, GSTP1 and CYP2E1 single nucleotide polymorphisms with colorectal cancer in Iran

Pathology and Oncology Research

Volumn 18, Issue 3, 2012, Pages 651-656

  Ebrahimkhani, Saeideh ^a   Asgharian, Ali Mohammad ^b   Nourinaier, Babak ^a   Ebrahimkhani, Khadijeh ^d   Vali, Nasrin ^a   Abbasi, Fatemeh ^c   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c Azarbaijan Tarbiat Molaem University   (Iran)

^d ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Cytochrome P4502E1; Glutathione S transferases; Iran

Indexed keywords

CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; CYP2E1 GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; IRAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP2E1; DNA; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IRAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84863983160     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9490-8     Document Type: Article

References (44)

1. Guengerich FP (1992) Metabolic activation of carcinogens. Pharmacol Ther 54:17-61
2. Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P- 450 enzymes. Chem Res Toxicol 4:391-407
3. Doll R, Peto R (1981) The causes of cancers: quantitative estimates of avoidable risks of cancers in the United States today. J Natl Cancer Inst 66(6):1191-1308
4. Chasseaud LF (1979) The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophiles agents. Adv Cancer Res 29:175-274
5. Coles B, Ketterer B (1990) The role of glutathione transferases in chemical carcinogenesis. Crit Rev Biochem MolBiol 25:47-70
6. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO (2001) The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 249:477-493
7. Kihara M, Kihara M, Noda K (1995) Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16:2331-2336
8. Lin DX, Tang YM, Peng Q, Lu SH, Ambrosone CB, Kadlubar FF (1998) Susceptibility to esophageal cancer and genetic polymorphisms in glutathione s- transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiology, Biomarker & Prey 7:1013-1018
9. Nebert DW, McKinnon RA, Puga A (1996) Human drug- metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15:273-280
10. Cheng KK, Day NE, Duffy SW, Lam TH, Fok M, Wong J (1992) Pickled vegetables in the aetiology of esophageal cancer in Hong Kong Chinese. Lancet 339:1314-1318
11. Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11(6):559-603
12. Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179
13. Gunter MJ,Watson MA, Loktionov AS et al (2005) No association between cytochrome P450 and glutathione S-transferase gene polymorphisms and risk of colorectal adenoma: results from the UK flexible sigmoidoscopy screening trial. Canc Epidemiol Biomarkers Prev 14(4):1028-30
14. Nakajima T, Wang R-S, Nimura Y et al (1996) Expression of cytochrome P450s and glutathione S- transferases in human esophagus with squamous- cell carcinomas. Carcinogenesis 17:1477-1481
15. Boyer TD, Kenney WC (1985) Preparation, characterization and properties of glutathione S-transferases. In: Zakim D, Vessey D (eds) Biochemical pharmacology and toxicology.Wiley, New York
16. Mannervik B, Awasthi YC, Board PG et al (1992) Nomenclature for human glutathione S-transferases. Biochem J 282:305-306
17. Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B (1991) θ, a new class of glutathione transferases purified from rat and man. Biochem J 274:409-414
18. Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF (1994) Effects of human and rat glutathione S-transferases on the covalent bonding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res 54:4920-4926
19. Pemble S, Schroeder KR, Spenser SR et al (1994) Human glutathione S-transferase (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276
20. EvansWE, RellingMV(1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487-91
21. Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev 6:733-743
22. Strange RC, Lear JT, Fryer AA (1998) Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact 24(111-112):351-364
23. Nomania H, Mohammadzadeh Ghobadloob S, Yaghmaeib B, Rezvaniea NA, Yaghmaeic K (2005) Glutathione S-transferases activity in patients with colorectal cancer. Clin Biochem 38:621-624
24. Rajagopal R, Deakin M, Fawole AS et al (2005) Glutathione Stransferase T1 polymorphisms are associated with outcome in colorectal cancer. Carcinogenesis 26(12):2157-2163
25. Srivastava SK, Singhal SS, Hu X, Awasthi YC, Zimniak P, Singh SV (1999) Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys 366:89-94
26. Houlston RS (1999) Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 8:675-682
27. Baily R, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl F (1998) Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58:65-70
28. Saadat I, Saadat M (2001) Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Letters 169:21-26
29. de Jong M, Nolte IM, te Meerman GJ et al (2002) Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 11:1332-52
30. Board PG (1981) Gene deletion and partial deficiency of the glutathione S-transferase (ligandin) system in man. FEBS Lett 135:12-14
31. Pemble S, Schroeder KR, Spencer SS, Meyer DJ, Hallier E, Bolt HM (1994) Human glutathione S-transferase (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. Biochem J 300:271-276
32. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J (1997) Molecular cloning, characterisation and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase ǒ variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272:10004-11112
33. Casson AG, Zheng Z, Chiasson D et al (2003) Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 27:139-146
34. Tan W, Song N, Wang GQ et al (2000) Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiology Biomarkers Prev 9:551-556
35. Butler WJ, Ryan P, Roberts-Thomson IC (2001) Metabolic genotypes and risk for colorectal cancer. J Gastroenterology Hepatol 16:631-635
36. Lu X M, Zang YM, Lin RY et al (2005) Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol 28: 11(24): 3651-3654.
37. Xing D, Tan W, Song N, Lin D (2000) Genetic polymorphism in hOGG1and susceptibility to esophageal cancer in Chinese. Zhonghuayixue Yichuanxue Zazhi 17:377-380
38. Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX (2001) Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int J Cancer 95:96-101
39. Tan W, Song N, Wang GQ et al (2000) Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 9:551-556
40. Dong CH, Yu SZ, Chen GC, Zhao DM, Hu Y (1998) Association of polymorphisms of glutathioneS transferase M1 and T1 genotypes with elevated aflatoxin and increased risk of primary liver cancer. Shijie Huaren Xiaohua Zazhi 6:463-466
41. Thong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993) Relationship between the GSTMI genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824
42. Chevenix-Trench G, Young J, Coggan M, Board P (1995) Glutathione S-transferase Ml, and Tl polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16:1655-1657
43. Katoh T, Nagata N, Kuroda Y et al (1996) Glutathione Stransferase MI (GSTM1), and Tl(GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17:1855-1859
44. Deakin M, Elder J, Hendrickse C et al (1996) Glutathione Stransferase GSTI'l genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17:881-884